VRDN
#1924
Viridian Therapeutics, Inc. - Common Stock
18.2 2 USD
0.00%
Market Price
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-0.44%
Variazione Mensile
-17.11%
Variazione di 6 mesi
+19.63%
Variazione Annuale
-18.84%
Chiusura Precedente
18.3 0
Open
18.0 4
Minimo
17.9 6
Massimo
18.3 3
Financials
2017
Quarterly report, Q1 FY2017
Viridian Therapeutics, Inc. quarterly report, Q1 FY2017
10-Q
Current report, 31 Mar 2017
Viridian Therapeutics, Inc. current report, 31 March 2017
8-K
Current report, 24 Mar 2017
Viridian Therapeutics, Inc. current report, 24 March 2017
8-K
Current report, 13 Feb 2017
Viridian Therapeutics, Inc. current report, 13 February 2017
8-K
Current report, 10 Feb 2017
Viridian Therapeutics, Inc. current report, 10 February 2017
8-K
Current report, 09 Jan 2017
Viridian Therapeutics, Inc. current report, 09 January 2017
8-K
2016
Annual report, FY2016
Viridian Therapeutics, Inc. annual report, FY2016
10-K
Current report, 29 Nov 2016
Viridian Therapeutics, Inc. current report, 29 November 2016
8-K
Current report, 29 Nov 2016
Viridian Therapeutics, Inc. current report, 29 November 2016
8-K
Current report, 28 Nov 2016
Viridian Therapeutics, Inc. current report, 28 November 2016
8-K